⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
JUBLPHARMA - IntraDay Trade Analysis with Live Signals
Last Updated Time : 05 Nov 25, 7:43 am
Back to IntraDay Trade ListIntraDay Trade Rating: 2.8
📈 Optimal Trade Setup
- Buy Price: ₹1,170–₹1,178 (only if price sustains above ₹1,170 with volume confirmation).
- Profit Exit Level: ₹1,190–₹1,200 (short-term resistance zone).
- Stop-Loss: ₹1,160 (below recent support and psychological level).
📊 If Already Holding
- Exit Signal: RSI at 64.4 is bullish but nearing overbought — watch for reversal signs.
- Volume: Current volume (2.67L) is below 1-week average (4.01L) — weak intraday momentum.
- Exit Point: Consider exiting near ₹1,190–₹1,200 unless MACD strengthens and volume spikes intraday.
✅ Positive
- MACD at 14.9 and RSI above 60 — bullish momentum.
- Price above both 50 DMA (₹1,109) and 200 DMA (₹1,059) — strong technical setup.
- DII holding increased by 1.01% — improving domestic sentiment.
- Debt-to-equity ratio of 0.02 — excellent financial stability.
⚠️ Limitation
- Volume below average — limited intraday interest.
- ROCE 2.91% and ROE 1.04% — weak capital efficiency.
- EPS of ₹1.15 — low earnings per share.
- Missing P/E and PEG ratios — valuation unclear.
📰 Company Negative News
- Quarterly PAT dropped from ₹4.10 Cr. to -₹48.0 Cr. — 436% decline, indicating severe earnings pressure.
- FII holding declined by 0.84% — cautious foreign sentiment.
📢 Company Positive News
- Despite earnings dip, technical indicators show short-term bullish momentum.
🏗️ Industry
- Industry PE at 33.1 — JUBLPHARMA valuation unclear due to missing P/E.
- Pharma sector showing mixed signals amid regulatory shifts and margin pressures.
🧾 Conclusion
- JUBLPHARMA is a cautious intraday candidate today with bullish technical indicators but weak fundamentals and low volume.
- Entry near ₹1,178 is viable if volume improves; exit near ₹1,200 for short-term gains.
- If already holding, monitor RSI and MACD for continuation or reversal signals intraday.
I can also help you compare JUBLPHARMA’s setup with peers like Divi’s Labs or Granules India to identify stronger intraday momentum trades.
Back to IntraDay Trade ListNIFTY 50 - Today Top Intraday Trade Stock Picks
NEXT 50 - Today Top Intraday Trade Stock Picks
MIDCAP - Today Top Intraday Trade Stock Picks
SMALLCAP - Today Top Intraday Trade Stock Picks